A Phase 1, Single Dose, Open-label, Safety, Tolerability, and Pharmacokinetic Study of LYN-014 in Individuals with Opioid Use Disorder who are Stable on Methadone Therapy
A Study of LYN-014 in Individuals with Opioid Use Disorder who are Stable on Methadone Therapy
Sponsor: Lyndra
Enrolling: Male and Female Patients
Study Length: 45 Days
IRB Number: 8188
U.S. Govt. ID: NCT05251376
Contact: Rachel Luba: 646-774-6243 / rachel.luba@nyspi.columbia.edu
Additional Study Information: Have an Opioid Use Disorder? We need your help for an inpatient clinical research study! Help the New York State Psychiatric Institute research better treatment options for those with opioid use disorder.You could earn up to $12,017.00.You must meet the following criteria: - Age 18 -59 years old- Have opioid use disorder- Be currently taking an oral daily methadone therapy at a dose of 60-120 mg Call: 646-774-6243 to learn more
This study is closed
Investigator
Sandra Comer, PhD
Do You Qualify?
Are you currently taking an oral methadone dose of 60-120 mg? Yes No
Are you between the ages of 18 and 59? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Rachel Luba
rachel.luba@nyspi.columbia.edu
646-774-6243